0.68 - 0.75
0.33 - 0.86
12.80M / 4.66M (Avg.)
35.00 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.84%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
17.03%
Positive gross profit growth while 0335.HK is negative. John Neff would see a clear operational edge over the competitor.
39.17%
EBIT growth 1.25-1.5x 0335.HK's 31.52%. Bruce Berkowitz would verify if strategic initiatives are driving this edge.
39.17%
Operating income growth 1.25-1.5x 0335.HK's 31.54%. Bruce Berkowitz would see if strategic measures (e.g., cost cutting, product mix) are succeeding.
12.12%
Net income growth under 50% of 0335.HK's 453.95%. Michael Burry would suspect the firm is falling well behind a key competitor.
13.73%
EPS growth under 50% of 0335.HK's 452.71%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
13.73%
Diluted EPS growth under 50% of 0335.HK's 452.71%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-1.45%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-1.36%
Reduced diluted shares while 0335.HK is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-140.53%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-128.18%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
48403.57%
10Y revenue/share CAGR above 1.5x 0335.HK's 6.94%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
21.62%
5Y revenue/share CAGR at 50-75% of 0335.HK's 31.84%. Martin Whitman would worry about a lagging mid-term growth trajectory.
2.09%
3Y revenue/share CAGR under 50% of 0335.HK's 105.38%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-54872.48%
Negative 10Y OCF/share CAGR while 0335.HK stands at 61.69%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-12824.71%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-708.35%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
231.68%
Net income/share CAGR above 1.5x 0335.HK's 68.06% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
3699.57%
5Y net income/share CAGR above 1.5x 0335.HK's 301.59%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
574.70%
3Y net income/share CAGR above 1.5x 0335.HK's 28.94%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
96.16%
5Y equity/share CAGR is in line with 0335.HK's 94.09%. Walter Schloss would see parallel mid-term profitability and retention policies.
39.07%
3Y equity/share CAGR at 50-75% of 0335.HK's 62.39%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
No Data
No Data available this quarter, please select a different quarter.
-23.04%
Firm’s AR is declining while 0335.HK shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
15.68%
Inventory shrinking or stable vs. 0335.HK's 12541.67%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
-13.03%
Negative asset growth while 0335.HK invests at 8.10%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
7.65%
75-90% of 0335.HK's 9.31%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
2122.61%
Debt growth far above 0335.HK's 729.91%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-25.80%
Our R&D shrinks while 0335.HK invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
25.32%
SG&A growth well above 0335.HK's 6.74%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.